Immatics Biotechnologies GmbH
Hiring for 3 positions
Immatics Biotechnologies GmbH pioneers precision targeting of PRAME, a critical indicator across over 50 cancer types. Our focus is on developing innovative PRAME immunotherapies, including TCR T-cell therapies and bispecifics, making meaningful strides in cancer treatment.
No jobs found. Subscribe below to get notified when we find something for you.
Searching